| |
| |
|
| Insider
Information: |
Bergstrom Donald A |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
527,427 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,502,115 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
527,427 |
|
|
| Total
Value |
$3,502,115 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -591.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mersana Therapeutics, Inc. |
MRSN |
|
|
0 |
|
0 |
Premium* |
|
|
Relay Therapeutics, Inc. |
RLAY |
|
2024-04-29 |
527,427 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RLAY |
Relay Therapeutics, Inc. |
See RemarksOfficer |
• – – |
2020-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
98,566 |
|
- |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
34,999 |
133,565 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-04-16 |
4 |
AS |
$32.36 |
$1,822,645 |
D/D |
(56,324) |
77,241 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-06-16 |
4 |
OE |
$4.12 |
$174,037 |
D/D |
42,242 |
119,483 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-06-16 |
4 |
AS |
$33.75 |
$1,425,668 |
D/D |
(42,242) |
77,241 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-06-28 |
4 |
S |
$35.81 |
$34,951 |
D/D |
(976) |
76,265 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-09-27 |
4 |
S |
$36.87 |
$23,818 |
D/D |
(646) |
75,619 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-10-15 |
4 |
AS |
$34.15 |
$1,024,500 |
D/D |
(30,000) |
45,619 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-12-27 |
4 |
S |
$33.10 |
$21,482 |
D/D |
(649) |
44,970 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
64,950 |
109,920 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-02-22 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
117,920 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-02-22 |
4 |
AS |
$20.94 |
$481,577 |
D/D |
(22,994) |
94,926 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-03-01 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
102,926 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-03-01 |
4 |
AS |
$23.88 |
$191,040 |
D/D |
(8,000) |
94,926 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-03-10 |
4 |
AS |
$25.00 |
$250,000 |
D/D |
(10,000) |
94,926 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-03-10 |
4 |
OE |
$4.12 |
$41,200 |
D/D |
10,000 |
104,926 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-03-24 |
4 |
OE |
$4.12 |
$41,200 |
D/D |
10,000 |
104,926 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-03-24 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
94,926 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-03-29 |
4 |
S |
$29.87 |
$18,579 |
D/D |
(622) |
94,304 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-04-01 |
4 |
OE |
$4.12 |
$74,160 |
D/D |
18,000 |
112,304 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-04-01 |
4 |
AS |
$30.32 |
$545,760 |
D/D |
(18,000) |
94,304 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-04-28 |
4 |
AS |
$25.57 |
$46,307 |
D/D |
(1,811) |
92,493 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-05-02 |
4 |
AS |
$24.62 |
$320,060 |
D/D |
(13,000) |
92,493 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-05-02 |
4 |
OE |
$4.12 |
$53,560 |
D/D |
13,000 |
105,493 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-06-24 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
100,493 |
0 |
- |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
